Healthcare provider profile · identity verified

Daniel Conger Linfesty, M.D.

Internal Medicine · CITRUS HEIGHTS, CA · NPI 1710325402

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	331	102
Levothyroxine Sodium	Levothyroxine Sodium	232	70
Losartan Potassium	Losartan Potassium	215	56
Amlodipine Besylate	Amlodipine Besylate	211	68
Lisinopril	Lisinopril	207	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	49
Omeprazole	Omeprazole	171	62
Gabapentin	Gabapentin	151	49
Rosuvastatin Calcium	Rosuvastatin Calcium	130	44
Tamsulosin Hcl	Tamsulosin Hcl	114	45
Hydrochlorothiazide	Hydrochlorothiazide	107	30
Tramadol Hcl	Tramadol Hcl	97	26
Pantoprazole Sodium	Pantoprazole Sodium	96	27
Trazodone Hcl	Trazodone Hcl	94	33
Metformin Hcl	Metformin Hcl	82	28
Citalopram Hbr	Citalopram Hydrobromide	76	16
Metoprolol Succinate	Metoprolol Succinate	76	20
Simvastatin	Simvastatin	75	29
Fluticasone Propionate	Fluticasone Propionate	74	31
Albuterol Sulfate Hfa	Albuterol Sulfate	72	27
Furosemide	Furosemide	72	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	70	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	11
Duloxetine Hcl	Duloxetine Hcl	66	18
Fluoxetine Hcl	Fluoxetine Hcl	65	13
Zolpidem Tartrate	Zolpidem Tartrate	63	16
Metoprolol Tartrate	Metoprolol Tartrate	62	19
Sertraline Hcl	Sertraline Hcl	62	24
Celecoxib	Celecoxib	58	23
Finasteride	Finasteride	57	20
Potassium Chloride	Potassium Chloride	57	16
Spironolactone	Spironolactone	52	14
Trulicity	Dulaglutide	52	13
Famotidine	Famotidine	51	15
Benazepril Hcl	Benazepril Hcl	50	15
Jardiance	Empagliflozin	49	12
Januvia	Sitagliptin Phosphate	47	13
Buspirone Hcl	Buspirone Hcl	46	15
Escitalopram Oxalate	Escitalopram Oxalate	45	suppressed
Montelukast Sodium	Montelukast Sodium	45	12
Carvedilol	Carvedilol	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	12
Lorazepam	Lorazepam	43	suppressed
Metformin Hcl Er	Metformin Hcl	42	12
Pravastatin Sodium	Pravastatin Sodium	40	16
Triamcinolone Acetonide	Triamcinolone Acetonide	36	20
Cephalexin	Cephalexin	35	16
Ibuprofen	Ibuprofen	35	suppressed
Ozempic	Semaglutide	35	suppressed
Allopurinol	Allopurinol	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Ezetimibe	Ezetimibe	32	14
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Prednisone	Prednisone	32	18
Eliquis	Apixaban	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Ventolin Hfa	Albuterol Sulfate	28	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Diazepam	Diazepam	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Mounjaro	Tirzepatide	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Atenolol	Atenolol	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Baclofen	Baclofen	23	12
Spiriva Respimat	Tiotropium Bromide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Amoxicillin	Amoxicillin	21	16
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Hydrocortisone	Hydrocortisone	21	12
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Ketoconazole	Ketoconazole	20	suppressed
Estradiol	Estradiol	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Prazosin Hcl	Prazosin Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Azithromycin	Azithromycin	16	16
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Digoxin	Digoxin	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Atrovent Hfa	Ipratropium Bromide	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Glipizide	Glipizide	11	suppressed
Lamotrigine Er	Lamotrigine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error